The Board of ARS Pharmaceuticals has appointed current President Donn Casale as CEO and Director effective July 7, 2026. Mr. Casale has 25+ years of biopharmaceutical business and commercial leadership experience. He previously served as Chief Commercial Officer at Dynavax Technologies, held marketing and sales operations leadership positions at Depomed, and spent 14 years at Merck in sales, marketing, and corporate strategy roles.

—Please visit https://ir.ars-pharma.com/news-releases/news-release-details/ars-pharmaceuticals-announces-ceo-succession to learn more.